chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: HIBV
Symptoms: No adverse event, Poor quality product administered, Product storage error
Clinical narrative: Act-HIB for which cold chain break is reported with no reported adverse event; Poor quality vaccine administered with no reported adverse event; Initial information received on 19-Apr-2023 regarding an unsolicited valid  non-serious case received from a physician.  This case is linked to cases 2023SA124713 and 2023SA129811.  This case involves Infant and unknown gender patient for whom poor quality vaccine HIB (PRP/T) vaccine [ACT-HIB] administered of which cold chain break with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect HIB (PRP/T) vaccine Powder and solvent for solution for injection with unknown strength, dose, batch number, expiry date via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the cold chain break is reported with no reported adverse event (product storage error) and patient received a dose of suspect HIB (PRP/T) vaccine powder and solvent for solution for injection with unknown strength, dose, batch number, expiry date via unknown route in unknown administration site for prophylactic vaccination was administered with no reported adverse event (poor quality product administered) (latency: same day).  It is unknown if the patient experienced any additional symptoms/events.   It is unknown if there were lab data/results available.   Action taken: not applicable.  At time of reporting, the outcome was Unknown for both the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: HIBV
Symptoms: No adverse event, Poor quality product administered, Product storage error
Clinical narrative: broken cold chain until two weeks after the shipment arrived with no reported adverse event; after excursion, vaccine was administered with no reported adverse event; Initial information received on 19-Apr-2023 regarding an unsolicited valid non-serious case received from a physician.  This case involves Infant and unknown gender patient and reporter reported broken cold chain for haemophilus type B (HIB) (PRP/T) vaccine [ACT-HIB] until two weeks after the shipment arrived with no reported adverse event and after excursion, vaccine was administered with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect haemophilus type B (HIB) (PRP/T) vaccine Powder and solvent for solution for injection (lot number, strength, dosage, expiry date- not reported) via unknown route in unknown administration site for prophylactic vaccination. Information on the batch number was requested  Caller reported broken cold chain for haemophilus type B (HIB) (PRP/T) vaccine [ACT-HIB] until two weeks after the shipment arrived with no reported adverse event (product storage error) (unknown latency) and after excursion, vaccine was administered with no reported adverse event (poor quality product administered) (latency- same day).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for both the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  2023SA124713:master case
Sex: U
Vaccine: IPV
Symptoms: No adverse event, Poor quality product administered, Product storage error
Clinical narrative: Temperature excursion for opened IPOL with no adverse event; product administered to a patient with no adverse event; Initial information received on 27-Apr-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves an unknown age and gender patient who was administered IPV (vero) [IPOL] that underwent temperature excursion with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect IPV (vero) (lot: Z1B901M, V1A121M; expiry date: 02-Jun-2024, 15-Feb-24) via unknown route in unknown administration site for immunization that underwent temperature excursion (product storage error) (poor quality product administered) (same day latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event temperature excursion for opened ipol with no adverse event and was Unknown for the event product administered to a patient with no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.0
Sex: F
Vaccine: IPV
Symptoms: Extra dose administered, Medication error, No adverse event
Clinical narrative: accidentally administration of extra dose with no reported adverse event; Initial information was received  on 27-Apr-2023 regarding an unsolicited valid non-serious case received from an other health professional.  This case involves a 12 months old female patient who involved in accidentally administration of extra dose of poliomyelitis vaccine (inactivated) [ipol] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HIB VACCINE CONJ (TET TOX) (ACTHIB) for prophylactic vaccination (Immunisation); pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13) for prophylactic vaccination (Immunisation); and measles vaccine live (enders-edmonston), mumps vaccine live (jeryl lynn), rubella vaccine live (wistar ra 27/3), varicella zoster vaccine live (OKA/MERCK) (Proquad) for prophylactic vaccination (Immunisation);  On an unknown date, the patient received accidentally extra 0.5 ml total dose of suspect poliomyelitis vaccine (inactivated) Suspension for injection (lot number: V1V891M, expiration date: 01-Jun-2023, strength, administration site: Unknown) via intramuscular route for prophylactic vaccination (immunization) with no reported adverse event (extra dose administered) (latency: same day)  No lab data reported.  Action taken: not applicable.  Outcome: Unknown for the event accidentally administration of extra dose with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 74.0
Sex: M
Vaccine: TDAP
Symptoms: Medication error, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: gave Adacel to an elderly patient with no reported adverse event; Initial information received on 28-Apr-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 74 years old male patient (59 kg) and it was reported Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] was given to an elderly patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 28-Apr-2023, the patient received 0.5 ml of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine Suspension for injection (lot number: U7648AA, Expiry date: 15-Feb-2025) (Frequency-once; Strength: Standard) via intramuscular route in the right deltoid for immunization.  On 28-Apr-2023, it was reported Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] was given to an elderly patient with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day).  It was reported, Caller, a pharmacist intern, stated he has a clinical question about Adacel. Caller stated they gave Adacel to an adult more than 130 pounds with a 5/8th inch needle. Caller asked if the vaccine would be effective for tetanus and diptheria or would the patient need revaccination. Caller states that ADACEL was administered to a patient intramuscular in the right deltoid but was administered with a 5/8th inch needle. They are inquiring if this dose be counted as valid.  Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 18.0
Sex: F
Vaccine: MEN
Symptoms: Extra dose administered, Medication error, No adverse event
Clinical narrative: patient received an extra dose of MENQUADFI with no reported adverse event; Initial information received on 28-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 18 years old female patient where patient received an extra dose of menquadfi with no reported adverse event while receiving vaccine meningococcal a-c-y-w135 (t conj) vaccine [Menquadfi].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hpv vaccine vlp rl1 4v (yeast) (gardasil) and meningococcal vaccine b rfhbpa/fhbpb (trumenba) for Immunisation.  On 28-Apr-2023, the patient received 0.5 ml dose of suspect meningococcal a-c-y-w135 (t conj) vaccine Solution for injection (frequency- daily) (batch number- U7447AC and expiration date-20-Sep-2024) via intramuscular route in the right arm (strength: not provided).  On 28-Apr-2023 the patient received an extra dose of menquadfi with no reported adverse event (extra dose administered) (latency- same day) following the administration of meningococcal a-c-y-w135 (t conj) vaccine.  Action taken- Not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.25
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: received a dose of ACTHIB in which the diluent is expired, with no reported adverse event; Initial information received on 01-May-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 15 months old female patient who received a dose of HIB (PRP/T) vaccine [ACT-HIB] in which the diluent is expired, with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 01-May-2023, the patient received 0.25 mL to 2 mL dose of suspect HIB (PRP/T) vaccine (Powder and solvent for solution for injection) (Lot number = UJ677AA (carton) UJ677AA (product) U7261AA (diluent) (Expiry Date for all the Lots = JUNE 5, 2023 (product) APRIL 7, 2023 (carton and diluent) Frequency = Once, Dose = 0.1 mL for TB skin test = 0.5ml, (Strength = standard) via intramuscular route in the thigh not otherwise specified (nos) for Immunization or TB skin test.   On 01-May-2023, the patient received a dose of HIB (PRP/T) vaccine in which the diluent is expired, with no reported adverse event (expired product administered) (latency: same day).  Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blood cortisol, Blood test, Colonoscopy, Constipation
Clinical narrative: Immediately following I started to notice abdominal discomfort. A month out I had gained 30 lbs. I have been the same weight since I was 15, approximately 125 give or take 10 lbs. I began experiencing diarrhea and then extreme constipation. The constipation was so severe I had to start seeing a GI due to the extreme pain, nausea, lightheadedness, etc. Simulataneously I developed nummular eczema, and eczema around my hairline, which I had never had prior. The nummular eczema cleared up once I was prescribed a steroid cream. The eczema around my hairline is still present but isn?t as troubling as the IBS. The IBS has caused me to miss work due to inability to be away from the toilet, nausea, vomiting, and extreme abdominal pain. This all began after the Pfizer vaccine was ACCIDENTALLY administered. I had 2 Moderna vaccines prior and was under the impression I was getting a third one. The technician informed me that it was Pfizer after the fact and apologized.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Eczema, Eczema nummular, Immediate post-injection reaction
Clinical narrative: Immediately following I started to notice abdominal discomfort. A month out I had gained 30 lbs. I have been the same weight since I was 15, approximately 125 give or take 10 lbs. I began experiencing diarrhea and then extreme constipation. The constipation was so severe I had to start seeing a GI due to the extreme pain, nausea, lightheadedness, etc. Simulataneously I developed nummular eczema, and eczema around my hairline, which I had never had prior. The nummular eczema cleared up once I was prescribed a steroid cream. The eczema around my hairline is still present but isn?t as troubling as the IBS. The IBS has caused me to miss work due to inability to be away from the toilet, nausea, vomiting, and extreme abdominal pain. This all began after the Pfizer vaccine was ACCIDENTALLY administered. I had 2 Moderna vaccines prior and was under the impression I was getting a third one. The technician informed me that it was Pfizer after the fact and apologized.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Interchange of vaccine products, Irritable bowel syndrome, Nausea, Overweight
Clinical narrative: Immediately following I started to notice abdominal discomfort. A month out I had gained 30 lbs. I have been the same weight since I was 15, approximately 125 give or take 10 lbs. I began experiencing diarrhea and then extreme constipation. The constipation was so severe I had to start seeing a GI due to the extreme pain, nausea, lightheadedness, etc. Simulataneously I developed nummular eczema, and eczema around my hairline, which I had never had prior. The nummular eczema cleared up once I was prescribed a steroid cream. The eczema around my hairline is still present but isn?t as troubling as the IBS. The IBS has caused me to miss work due to inability to be away from the toilet, nausea, vomiting, and extreme abdominal pain. This all began after the Pfizer vaccine was ACCIDENTALLY administered. I had 2 Moderna vaccines prior and was under the impression I was getting a third one. The technician informed me that it was Pfizer after the fact and apologized.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Stool analysis, Vomiting, Weight increased
Clinical narrative: Immediately following I started to notice abdominal discomfort. A month out I had gained 30 lbs. I have been the same weight since I was 15, approximately 125 give or take 10 lbs. I began experiencing diarrhea and then extreme constipation. The constipation was so severe I had to start seeing a GI due to the extreme pain, nausea, lightheadedness, etc. Simulataneously I developed nummular eczema, and eczema around my hairline, which I had never had prior. The nummular eczema cleared up once I was prescribed a steroid cream. The eczema around my hairline is still present but isn?t as troubling as the IBS. The IBS has caused me to miss work due to inability to be away from the toilet, nausea, vomiting, and extreme abdominal pain. This all began after the Pfizer vaccine was ACCIDENTALLY administered. I had 2 Moderna vaccines prior and was under the impression I was getting a third one. The technician informed me that it was Pfizer after the fact and apologized.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Episode of Shingles; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number 9HM59, expiry date 30-SEP-2023) for prophylaxis.   On 15-NOV-2022, the patient received the 1st dose of Shingrix. In DEC-2022, less than 2 months after receiving Shingrix, the patient experienced shingles (Verbatim: Episode of Shingles). The outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     It was unknown if the company considered the shingles to be related to Shingrix.   Additional Information: GSK receipt date: 26-APR-2023 The pharmacist reports patient experienced an episode of shingles after 1st Shingrix vaccine that was administered on 15th November 2022. The patient developed Shingles in December 2022. The patient was back today to receive 2nd Shingrix vaccine.  Unknown when shingles resolved.  Shingrix not administered at time of call. The reporter consented to follow up.
Age: 90.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO LOCAL HEALTHCARE UNIT WHICH WAS ADMINISTERED.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE NON ST ELEVATION MI
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: PRIVACY PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO PRIVACY HEALTHCARE @ PRIVACY. WHICH WAS ADMINISTERED.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE   ACUTE NON ST ELEVATION MI
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: PRIVACY PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO PRIVACY HEALTHCARE @ PRIVACY. WHICH WAS ADMINISTERED.
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO NURSING HOME WHICH WAS ADMINISTERED.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE ON CHRONIC RESPIRATORY FAILURE
Age: 90.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO NURSING HOME/SENIOR LIVING FACILITY.WHICH WAS ADMINISTERED.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO HEALTHCARE WHICH WAS ADMINISTERED.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO NURSING HOME/SENIOR LIVING FACILITY.WHICH WAS ADMINISTERED.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: It started with a sore throat then a headache and fever. I went to urgent care locally. I was given a COVID-19 test and it was positive. I emailed my PCP and I was emailed back to take PAXLOVID and took it for five days and then I was back to normal.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO NURSING HOME/SENIOR LIVING FACILITY.WHICH WAS ADMINISTERED.
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ear discomfort, Haemoptysis, Oropharyngeal pain, Pain, Productive cough
Clinical narrative: I experienced a fever after being vaccinated then I got my fever to break, my throat hurts, body aches, ears clogged, congestion and coughing up phlegm with blood in it.
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Respiratory tract congestion
Clinical narrative: I experienced a fever after being vaccinated then I got my fever to break, my throat hurts, body aches, ears clogged, congestion and coughing up phlegm with blood in it.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Hypotension
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE NON ST ELEVATION MI HYPOTENSION
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Hypoxia
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Bivalent Covid given as 2nd dose 4wks and 2d after the first orig  Covid dose because the rules around Covid vaccination couldn't be more complicated if you tried.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE DVT OF LEFT FEMORAL VEIN ACUTE DVT OF LEFT POPLITEAL VEIN
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE RESPIRATORY FAILURE
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Hypercapnia, Pulmonary embolism
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE PULMONARY EMBOLISM CHRONIC HYPERCAPNIC RESPIRATORY FAILURE
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired Covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Malaise, Oropharyngeal pain, Pain in extremity
Clinical narrative: I had a sore arm for a couple of days after receiving the vaccine. On 03/27/2023 I had a sore throat, tired and I just didn't feel good. I tested positive for COVID-19 on 03/29/2023. I contacted my doctor via patient chart and later I talked to a physician assistant. It was determined that my symptoms were not bad enough for PAXLOVID so I took FLONASE and ZYRTEC. I switched over to CLARITIN as I continue to have nasal discharge.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I had a sore arm for a couple of days after receiving the vaccine. On 03/27/2023 I had a sore throat, tired and I just didn't feel good. I tested positive for COVID-19 on 03/29/2023. I contacted my doctor via patient chart and later I talked to a physician assistant. It was determined that my symptoms were not bad enough for PAXLOVID so I took FLONASE and ZYRTEC. I switched over to CLARITIN as I continue to have nasal discharge.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Blood gases normal, Blood pH normal, Bronchiectasis, COVID-19, Computerised tomogram thorax abnormal
Clinical narrative: 67-year-old hypertensive, type 2 diabetic, not a known case of coronary artery disease, known case of chronic persistent or recurrent atrial fibrillation / flutter, status post multiple ablation and cardioversion, admitted from the office when he presented with worsening dyspnea and intractable cough.  Patient has been not feeling well since November when he was initially diagnosed in November 21, 2022 with COVID infection patient is fully vaccinated, he was treated with Paxlovid. Patient has been traveling, in March 2023 patient had bronchitis symptoms and was treated with Z-Pak with negative COVID-19 test, recurred with the symptoms and was treated with another dose of Z-Pak on May 1, 2023, he checked his COVID-19 testing at home and was negative. Before admission his COVID testing done to the hospital and reported to be positive.  Patient also have a history of sarcoidosis, suspicious of sarcoid exacerbation along with superimposed infection also discussed with the patient.  Started on IV Solu-Medrol, IV Zosyn, will consider remdesivir.  Placed on frequent nebulizer treatment and inhalers.  Patient also known case of obstructive sleep apnea, will continue on CPAP, will have a CT scan of the chest and ABG.  Patient is a known case of chronic persisting atrial fibrillation status post AV nodal ablation, with a pacemaker in place, continued on Eliquis.  Known case of type 2 diabetes mellitus, not on any medication, placed on insulin on low scale sliding scale.  The patient is not a smoker, occasional alcohol consumer, denies any drug use.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Cough, Dyspnoea, Interstitial lung disease, Lung opacity, Malaise
Clinical narrative: 67-year-old hypertensive, type 2 diabetic, not a known case of coronary artery disease, known case of chronic persistent or recurrent atrial fibrillation / flutter, status post multiple ablation and cardioversion, admitted from the office when he presented with worsening dyspnea and intractable cough.  Patient has been not feeling well since November when he was initially diagnosed in November 21, 2022 with COVID infection patient is fully vaccinated, he was treated with Paxlovid. Patient has been traveling, in March 2023 patient had bronchitis symptoms and was treated with Z-Pak with negative COVID-19 test, recurred with the symptoms and was treated with another dose of Z-Pak on May 1, 2023, he checked his COVID-19 testing at home and was negative. Before admission his COVID testing done to the hospital and reported to be positive.  Patient also have a history of sarcoidosis, suspicious of sarcoid exacerbation along with superimposed infection also discussed with the patient.  Started on IV Solu-Medrol, IV Zosyn, will consider remdesivir.  Placed on frequent nebulizer treatment and inhalers.  Patient also known case of obstructive sleep apnea, will continue on CPAP, will have a CT scan of the chest and ABG.  Patient is a known case of chronic persisting atrial fibrillation status post AV nodal ablation, with a pacemaker in place, continued on Eliquis.  Known case of type 2 diabetes mellitus, not on any medication, placed on insulin on low scale sliding scale.  The patient is not a smoker, occasional alcohol consumer, denies any drug use.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: PCO2 normal, PO2 normal, SARS-CoV-2 test positive, Symptom recurrence
Clinical narrative: 67-year-old hypertensive, type 2 diabetic, not a known case of coronary artery disease, known case of chronic persistent or recurrent atrial fibrillation / flutter, status post multiple ablation and cardioversion, admitted from the office when he presented with worsening dyspnea and intractable cough.  Patient has been not feeling well since November when he was initially diagnosed in November 21, 2022 with COVID infection patient is fully vaccinated, he was treated with Paxlovid. Patient has been traveling, in March 2023 patient had bronchitis symptoms and was treated with Z-Pak with negative COVID-19 test, recurred with the symptoms and was treated with another dose of Z-Pak on May 1, 2023, he checked his COVID-19 testing at home and was negative. Before admission his COVID testing done to the hospital and reported to be positive.  Patient also have a history of sarcoidosis, suspicious of sarcoid exacerbation along with superimposed infection also discussed with the patient.  Started on IV Solu-Medrol, IV Zosyn, will consider remdesivir.  Placed on frequent nebulizer treatment and inhalers.  Patient also known case of obstructive sleep apnea, will continue on CPAP, will have a CT scan of the chest and ABG.  Patient is a known case of chronic persisting atrial fibrillation status post AV nodal ablation, with a pacemaker in place, continued on Eliquis.  Known case of type 2 diabetes mellitus, not on any medication, placed on insulin on low scale sliding scale.  The patient is not a smoker, occasional alcohol consumer, denies any drug use.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, Condition aggravated, Fatigue, Thyroid disorder, Ultrasound thyroid normal
Clinical narrative: Around 3 months after receiving my first dose of Moderna, I was experiencing extreme fatigue. When I had my routine labs drawn for my thyroid values were askew. They were four times higher than I was in when I was first diagnosed with thyroid disease. That's been an ongoing problem. I have to have my labs drawn every 2 to 3 months and my medication is constantly changing. Prior to receiving my vaccines, I had been on the same dosages for 9 years.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ANGINA, UNSPECIFIED
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  NEUROPATHY
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I experienced a breakthrough case of COVID-19 with congestion, coughing and fatigue.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vaccine breakthrough infection
Clinical narrative: I experienced a breakthrough case of COVID-19 with congestion, coughing and fatigue.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Pulmonary embolism
Clinical narrative: ACUTE NON ST ELEVATION MI SINGLE SUBSEGMENTAL PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Neuropathy peripheral, Symptom recurrence
Clinical narrative: NEUROPATHY HYPOXIA  6/10/2022 &  7/17/2022  -- RECURRENCE OF SAME SYMPTOMS
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Product dose omission in error, Product preparation error
Clinical narrative: patient due for Rotavirus vaccine but was only given sterile diluent. pt did not get live virus. attempting to notify parents, will schedule for a nurse visit so patient can get dose that was missed . Unit manager and PCP notified.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 in 02/2023. I contacted my provider and got a prescription for Paxlovid. I tolerated the medication without any complications.  As of today, I am feeling better without any side effects.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE DVT, UNSPECIFIED VEIN
Age: 1.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Discontinued Pfizer Monovalent 6mo-4yr, No Adverse reactions reported by parent.
Age: 64.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Fatigue
Clinical narrative: 1/30/23  I woke up with a real bad sore throat. I thought I had a cold. I went to the clinic and was tested for COVID and it came back positive a few days later.  I lost my sense of taste and smell. I was very sleepy and exhausted. I went to the clinic and was prescribed Paxlovid. Within a day and a half of taking it, I felt much better. By 2/6/23 I felt better and the next day I got my sense of smell and taste back. Every once in a whle, I will still get something in my throat, like mucous. Sometimes something comes up and sometimes it does not. If I don?t take a cough drop, I will have a coughing fit.  I also feel like I am wheezing every once in a while.
Age: 64.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test positive, Sensation of foreign body, Somnolence
Clinical narrative: 1/30/23  I woke up with a real bad sore throat. I thought I had a cold. I went to the clinic and was tested for COVID and it came back positive a few days later.  I lost my sense of taste and smell. I was very sleepy and exhausted. I went to the clinic and was prescribed Paxlovid. Within a day and a half of taking it, I felt much better. By 2/6/23 I felt better and the next day I got my sense of smell and taste back. Every once in a whle, I will still get something in my throat, like mucous. Sometimes something comes up and sometimes it does not. If I don?t take a cough drop, I will have a coughing fit.  I also feel like I am wheezing every once in a while.
Age: 64.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Wheezing
Clinical narrative: 1/30/23  I woke up with a real bad sore throat. I thought I had a cold. I went to the clinic and was tested for COVID and it came back positive a few days later.  I lost my sense of taste and smell. I was very sleepy and exhausted. I went to the clinic and was prescribed Paxlovid. Within a day and a half of taking it, I felt much better. By 2/6/23 I felt better and the next day I got my sense of smell and taste back. Every once in a whle, I will still get something in my throat, like mucous. Sometimes something comes up and sometimes it does not. If I don?t take a cough drop, I will have a coughing fit.  I also feel like I am wheezing every once in a while.
Age: 1.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Discontinued pfizer monovalent 6mo-4yr , No adverse reaction reported by parent.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Pulmonary embolism, Respiratory failure, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/3/2022,  5/1/2022,  5/2/2022 --  RECURRENCE OF SAME SYMPTOMS
Age: 30.0
Sex: F
Vaccine: HPV9
Symptoms: Exposure during pregnancy
Clinical narrative: Gardasil #2 administered by clinic staff prior to discovering that the patient had a recent prenatal visit at outside facility. Unable to determine EDD based on prenatal progress notes, patient scheduled for dating ultrasound. Phone call to CDC-INFO for how to proceed. Patient notified that Gardasil not recommended during pregnancy and to reach out to Merck if adverse event occurs.
Age: 51.0
Sex: F
Vaccine: PNC20, TDAP
Symptoms: Presyncope
Clinical narrative: Patient nearly fainted
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Ischaemic stroke, Symptom recurrence
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY  5/5/2022 --  RECURRENCE OF SAME SYMPTOMS
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Face injury, Fall, Joint injury, Limb injury
Clinical narrative: Patient was brought to the local ER for complaints of a fall with injury to both knees , Left shoulder and face.  Placed in observation status for PT/OT evaluation and treatment.
Age: 0.75
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was administered ActHIB Vaccine on 4/13/23, the vaccine expired on 4/7/23. Patient has no adverse reactions to the vaccine.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Balance disorder, Cough, Feeling abnormal, Influenza A virus test negative, Influenza B virus test
Clinical narrative: I late December I started having a low-grade fever, congestion, a cough that was so bad it would knock me off my balance. I went to the local Urgent Care where they tested me for COVID-19 and Influenza A and B both test came back negative. I was given a prescription for benzonatate. In January I still felt bad, I went back to the Urgent Care where they tested me again for COVID-19 and Influenza A and B, this time I was given Amoxicillin. My ENT sent me to the hospital to stay on April 14, 21023 to get IV push medication for sinusitis bacterial infection  that is antibiotic resistant. I stayed there for two days. I will be having sinus surgery on Monday, May 8, 2023
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pathogen resistance, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative, Sinusitis bacterial
Clinical narrative: I late December I started having a low-grade fever, congestion, a cough that was so bad it would knock me off my balance. I went to the local Urgent Care where they tested me for COVID-19 and Influenza A and B both test came back negative. I was given a prescription for benzonatate. In January I still felt bad, I went back to the Urgent Care where they tested me again for COVID-19 and Influenza A and B, this time I was given Amoxicillin. My ENT sent me to the hospital to stay on April 14, 21023 to get IV push medication for sinusitis bacterial infection  that is antibiotic resistant. I stayed there for two days. I will be having sinus surgery on Monday, May 8, 2023
Age: 0.58
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Extra dose administered
Clinical narrative: Patient came in for 6month WCC 04/27/23. She received vaccines that day. When receiving and reviewing hospital records child received vaccines when she was in the hospital 03/27/23. When this was discovered I contacted all 3 manufacturers and reported incident along with requested information on what to monitor. I called mother 04/27/23 1330 x2 left voicemail. Text messages sent. Mother called office 04/28/23 I explained the situation to the mother. Mother reports that child is doing well. Having no symptoms. We discussed what to look out for and when to medical attention. Child was asymptomatic at WCC.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  HYPOTENSION
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Mobility decreased, Muscle swelling, Pain in extremity, Swelling face
Clinical narrative: swelling of deltoid and facial swelling.  Arm very painful and unable to use it according to patient.  Treated with ibuprofen.  Improving as of 24 hours later.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cerebral artery occlusion, Cerebrovascular accident
Clinical narrative: Pfizer vaccine was administered outside of clinic- reported by patient- ? NO LOT NUMBER WERE SUPPLIED -----------------------------------------------------------------------------------------------------------------------  ACUTE STROKE DUE TO OCCLUSION OF LEFT POSTERIOR CEREBRAL ARTERY 7/2/2021 ACUTE STROKE DUE TO OCCLUSION OF LEFT POSTERIOR CEREBRAL ARTERY  ACUTE STROKE DUE TO OCCLUSION OF LEFT POSTERIOR CEREBRAL ARTERY 7/2/2021 ATRIAL FIBRILLATION, UNSPECIFIED
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  NEUROPATHY
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Hepatic enzyme abnormal, Hypotension, Proctitis
Clinical narrative: I95.9 HYPOTENSION 11/22/2021 ATRIAL FIBRILLATION, UNSPECIFIED I95.9 HYPOTENSION 11/22/2021 ABNL LIVER ENZYMES I95.9 HYPOTENSION 11/22/2021 PROCTITIS
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Echocardiogram, Electrocardiogram, Heart rate irregular, Palpitations, Supraventricular tachycardia
Clinical narrative: I was diagnosed with SVT Tachycardia on February 11, 2023 my symptoms were heart pounding, irregular heart rate. I was prescribed metoprolol for my symptoms.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Hypotension
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE DVT OF RIGHT POPLITEAL VEIN HYPOTENSION
Age: 1.17
Sex: M
Vaccine: DTAP, HIBV, MMR, PNC13, VARCEL
Symptoms: Pyrexia, Seizure like phenomena
Clinical narrative: Telephone report for clients mother indicates child experienced seizure like activity that lasted approximately the morning after vaccination.  Some fever also noted by mother at the time.  Acetaminophen 2.5 ml given.  No fever at the time of the call at approximately 2pm on 5/2/2023.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Adenocarcinoma metastatic, Hypoxia, Metastases to lung, Sepsis
Clinical narrative: ACUTE RESPIRATORY FAILURE 4/28/2022 ADENOCARCINOMA METASTATIC TO LEFT LUNG HYPOXIA 4/28/2022 ADENOCARCINOMA METASTATIC TO LEFT LUNG ACUTE RESPIRATORY FAILURE 4/28/2022 SEPSIS WO ACUTE ORGAN DYSFUNCTION HYPOXIA 4/28/2022 SEPSIS WO ACUTE ORGAN DYSFUNCTION
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema
Clinical narrative: ANGIOEDEMA, INIT